BB
BAKER BROS. ADVISORS LP
DELAYED 1 MONTH
Director; Director, 10% Owner
ACADIA PHARMACEUTICALS INC
BeOne Medicines Ltd.
Denali Therapeutics Inc.
INCYTE CORP
Kiniksa Pharmaceuticals International, plc
Prelude Therapeutics Inc
TScan Therapeutics, Inc.
Filings
8
Companies
7
Latest
Jun 9, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
INCYTE CORP
BAKER BROS. ADVISORS LP
Director, 10% Owner
Option Exercise
$2.5M
30,000 sh
May 11 8:45 PM
May 8, 2026